Cargando…
Modern Lipid Management: A Literature Review
Pro-protein convertase subtilisin/Kexin type 9 (PCSK9) inhibitors are relatively new, non-statin, lipid-lowering drugs that reduce low-density lipoprotein cholesterol (LDL-C) by 60%. PCSK9 inhibitors reduce the blood concentrations of cholesterol by the degradation of LDL receptors, which subsequent...
Autores principales: | Malik, Jahanzeb, Shabeer, Hassan, Ishaq, Uzma, Chauhan, Humaira, Akhtar, Hina Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444996/ https://www.ncbi.nlm.nih.gov/pubmed/32850243 http://dx.doi.org/10.7759/cureus.9375 |
Ejemplares similares
-
Is There a Role for Colchicine in Acute Coronary Syndromes? A Literature Review
por: Malik, Jahanzeb, et al.
Publicado: (2020) -
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome) Mimicking a Stroke and Acute Coronary Syndrome: A Case Report
por: Ishaq, Uzma, et al.
Publicado: (2020) -
Clinical Outcomes of Mechanical Prosthetic Valve Thrombosis
por: Sharif Khan, Hamid, et al.
Publicado: (2020) -
Managing Postural Hypotension in Diabetic Autonomic Dysfunction When Adrenergic Drugs are Contraindicated: Case Report and Review of Literature
por: Bokhari, Syed Rizwan A, et al.
Publicado: (2018) -
Diurnal Variation in Outcomes of Percutaneous Coronary Intervention
por: Malik, Jahanzeb, et al.
Publicado: (2020)